Both in Pharmaceuticals
Janux Therapeutics vs Alto Neuroscience
Over the past year JANX returned −28.5% and ANRO returned +562.8%; their daily moves had a correlation of 0.18.
JANX −28.5% ANRO +562.8%Growth of $1, one year, split-adjusted
| Metric | JANX | ANRO |
|---|---|---|
| Price | $16.95 | $26.58 |
| Market cap | $1.04B | $1.04B |
| Today | +2.23% | −0.30% |
| 1 month | −6.0% | −24.3% |
| 6 months | +30.1% | +33.0% |
| Year to date | +22.8% | +49.3% |
| 1 year | −27.0% | +572.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −214.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 43.2× | — |
| Net cash | $970.9M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 46.4% | 55.6% |
| Short % of float | 13.8% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).